Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated With or Without Rituximab
Thrombosis and Haemostasis - Germany
doi 10.1055/s-0038-1668545
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 20, 2018
Authors
Publisher
Georg Thieme Verlag KG